246 related articles for article (PubMed ID: 33196757)
1. At-Home Transvaginal Device Following Fractional Carbon Dioxide Laser Treatment for Genitourinary Syndrome of Menopause.
Alexiades M
J Drugs Dermatol; 2020 Nov; 19(11):1076-1079. PubMed ID: 33196757
[TBL] [Abstract][Full Text] [Related]
2. Fractional Co
Alexiades MR
Lasers Surg Med; 2021 Feb; 53(2):185-198. PubMed ID: 32329093
[TBL] [Abstract][Full Text] [Related]
3. A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.
Cruff J; Khandwala S
J Sex Med; 2021 Apr; 18(4):761-769. PubMed ID: 33757774
[TBL] [Abstract][Full Text] [Related]
4. Safety and long-term efficacy of fractional CO
Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S
Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911
[TBL] [Abstract][Full Text] [Related]
5. Fractional and Microablative CO
Caceres Nogueira MC; Homem de Mello Bianchi-Ferraro AM; Leonor Pereira Campos M; Dias Oliveira C; Gracio Ferreira Sartori M; Di Bella ZIKJ; Logullo AF; ; Speck NMG
Photobiomodul Photomed Laser Surg; 2024 Jun; 42(6):414-421. PubMed ID: 38888192
[No Abstract] [Full Text] [Related]
6. Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women.
Samuels JB; Garcia MA
Aesthet Surg J; 2019 Jan; 39(1):83-93. PubMed ID: 29726916
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of fractional CO
Tovar-Huamani J; Mercado-Olivares F; Grandez-Urbina JA; Pichardo-Rodriguez R; Tovar-Huamani M; García-Perdomo H
Lasers Surg Med; 2019 Aug; 51(6):509-515. PubMed ID: 30779363
[TBL] [Abstract][Full Text] [Related]
8. The Fractional CO
Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
[TBL] [Abstract][Full Text] [Related]
9. Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results.
Athanasiou S; Pitsouni E; Grigoriadis T; Zacharakis D; Falagas ME; Salvatore S; Protopapas A; Loutradis D
Menopause; 2019 Mar; 26(3):248-255. PubMed ID: 30252804
[TBL] [Abstract][Full Text] [Related]
10. [Short-term efficacy of vaginal CO
Kozma B; Póka R; Sipos A; Ács N; Takács P
Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
[TBL] [Abstract][Full Text] [Related]
11. Does the Time of Onset of Urinary Symptoms Affect Microablative Fractional CO
Ruffolo AF; Casiraghi A; Marotta E; Degliuomini R; Parma M; Athanasiou S; Benini V; Candiani M; Salvatore S
Lasers Surg Med; 2021 Sep; 53(7):953-959. PubMed ID: 33476052
[TBL] [Abstract][Full Text] [Related]
12. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
13. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
Sokol ER; Karram MM
Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
[TBL] [Abstract][Full Text] [Related]
14. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence.
Arunkalaivanan A; Kaur H; Onuma O
Int Urogynecol J; 2017 May; 28(5):681-685. PubMed ID: 28154914
[TBL] [Abstract][Full Text] [Related]
15. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study.
Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z
Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
[TBL] [Abstract][Full Text] [Related]
18. CO
Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
[TBL] [Abstract][Full Text] [Related]
19. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
[TBL] [Abstract][Full Text] [Related]
20. Comparison of promestriene with vaginal fractional CO2 laser and radiofrequency treatments of genitourinary syndrome of menopause.
Seganfredo IB; Bianchi C; Tacla M; Chedraui P; Haddad JM; Simoes R; Baracat EC; Soares JM
Maturitas; 2024 Aug; 186():108008. PubMed ID: 38714422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
